| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 118 | 200.591 | 26.813 | 10.403 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 118 | 200.599 | 30.511 | 15.785 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 188 | 131.487 | 33.959 | 19.746 | 1.233 | 9 |
| Gross Profit/Loss - EUR | - | - | - | - | -70 | 69.111 | -3.448 | -3.961 | -1.233 | -9 |
| Net Profit/Loss - EUR | - | - | - | - | -73 | 64.971 | -3.716 | -4.157 | -1.233 | -9 |
| Employees | - | - | - | - | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Apep Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 588 | 5.013 | 608 | 606 | 603 |
| Current Assets | - | - | - | - | 314 | 87.941 | 44.695 | 10.607 | 6.191 | 6.147 |
| Inventories | - | - | - | - | 136 | 5.782 | 6.279 | 5.207 | 4.276 | 4.252 |
| Receivables | - | - | - | - | 118 | 65.026 | 2.557 | 1 | 1.758 | 1.728 |
| Cash | - | - | - | - | 59 | 17.133 | 35.859 | 5.399 | 157 | 167 |
| Shareholders Funds | - | - | - | - | -31 | 64.941 | 47.453 | 7.957 | 6.700 | 6.654 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 345 | 23.588 | 497 | 3.277 | 97 | 96 |
| Income in Advance | - | - | - | - | 0 | 0 | 1.774 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Apep Medical S.r.l.